Abbott and Reckitt's Mead Johnson face over 1,000 claims that preterm infant formula causes necrotizing enterocolitis (NEC) ...

(Bloomberg) -- Abbott Laboratories hid the risks of its premature-infant formula causing a potentially fatal bowel disease from parents even though company officials acknowledged the peril in ...

Abbott said the panel’s finding was consistent with years of studies that found its preterm baby formula was safe. The ...

JOLTs Job Openings Rise To 7.744 Million; Dow Jones Declines Below 44,700Tue, 03 Dec 2024 15:26:32 GMT ISM Manufacturing PMI Rises To 48.4; Dow Jones Pulls BackMon, 02 Dec 2024 17:13:12 GMT China ...

The trial was the first against both Mead Johnson and Abbott over cow's milk-based infant formula that lawsuits allege causes necrotizing enterocolitis, or NEC, in premature babies. Previous ...

Abbott sells about $9 million in nutritional ... In that statement, they confirmed, “There is no conclusive evidence that preterm infant formula causes NEC.” “Available evidence supports ...

A judge denied a request by Abbott Laboratories (NYSE:ABT) for a new trial after a St. Louis jury awarded a plaintiff $500 million in an infant formula case in July. Michael Noble of St.

Abbott (ABT) and Reckitt Benckiser’s (RBGLY ... accused the companies of failing to warn of the risks of premature baby formulas is a victory for the companies following large losses in similar ...

Investors feel optimistic about Abbott's robust strength in the EPD and Nutrition businesses. Yet, unfavorable forex impacts are concerning.

after winning a favorable ruling from a U.S. court in connection with a premature baby formula lawsuit. A jury cleared Reckitt’s unit Mead Johnson and Abbott Laboratories (ABT) of allegations ...

Shares in Reckitt Benckiser topped the Stoxx Europe 600 Index after a U.S. court cleared the company of liability in a case concerning its baby formulas.